- Home
- OTRK vs CYCN Comparison
OTRK vs CYCN Comparison
Compare OTRK & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTRK
- CYCN
- Stock Information
- Founded
- OTRK 2003
- CYCN 2018
- Country
- OTRK United States
- CYCN United States
- Employees
- OTRK N/A
- CYCN N/A
- Industry
- OTRK Misc Health and Biotechnology Services
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- OTRK Health Care
- CYCN Health Care
- Exchange
- OTRK Nasdaq
- CYCN Nasdaq
- Market Cap
- OTRK 6.1M
- CYCN 6.5M
- IPO Year
- OTRK N/A
- CYCN N/A
- Fundamental
- Price
- OTRK $0.53
- CYCN $2.81
- Analyst Decision
- OTRK Strong Buy
- CYCN
- Analyst Count
- OTRK 1
- CYCN 0
- Target Price
- OTRK $45.00
- CYCN N/A
- AVG Volume (30 Days)
- OTRK 197.8K
- CYCN 21.8K
- Earning Date
- OTRK 08-07-2025
- CYCN 08-06-2025
- Dividend Yield
- OTRK N/A
- CYCN N/A
- EPS Growth
- OTRK N/A
- CYCN N/A
- EPS
- OTRK N/A
- CYCN N/A
- Revenue
- OTRK $10,183,000.00
- CYCN $2,081,000.00
- Revenue This Year
- OTRK $50.12
- CYCN N/A
- Revenue Next Year
- OTRK $55.26
- CYCN N/A
- P/E Ratio
- OTRK N/A
- CYCN N/A
- Revenue Growth
- OTRK N/A
- CYCN N/A
- 52 Week Low
- OTRK $0.50
- CYCN $1.27
- 52 Week High
- OTRK $5.53
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- OTRK 18.63
- CYCN 41.24
- Support Level
- OTRK $1.45
- CYCN $3.02
- Resistance Level
- OTRK $1.39
- CYCN $3.16
- Average True Range (ATR)
- OTRK 0.07
- CYCN 0.21
- MACD
- OTRK -0.05
- CYCN -0.03
- Stochastic Oscillator
- OTRK 6.87
- CYCN 16.26
About OTRK Ontrak Inc.
Ontrak Inc is an artificial intelligence (AI)-powered and technology-enabled behavioral healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The group provides a value-based behavioral healthcare company that identifies and engages people with unmet health needs using the proprietary Advanced Engagement System to improve clinical outcomes and reduce total cost of care. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.